| Typicality: | 0.589 |
| Saliency: | 0.540 |
| to ensure | 12 | purpose |
| in those cases | 10 | temporal |
| to expedite the drug's development | 7 | purpose |
| agency → work with → company | 45 |
| agency → work with → the company | 10 |
| agency → worked with → company | 7 |
| negative | neutral | positive |
| 0.064 | 0.567 | 0.368 |
| Raw frequency | 62 |
| Normalized frequency | 0.540 |
| Modifier score | 0.833 |
| Perplexity | 241.231 |